ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Top Neurology Prescribers in Rhode Island

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
KENNETH RICKLER MD

Neurology

12,209

$1.18M

313
41 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 21%

$96
Average prescription price

Avg: $164

JOSEPH FRIEDMAN MD

Neurology

6,420

$814K

575
475 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 21%

$127
Average prescription price

Avg: $164

SUSANNE PATRICK-MACKINNON MD

Neurology

5,128

$522K

312
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 21%

$102
Average prescription price

Avg: $164

ALBERT MARANO M.D.

Neurology

4,053

$938K

434
311 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 21%

$231
Average prescription price

Avg: $164

DENNIS AUMENTADO M.D.

Neurology

3,834

$816K

340
251 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

32%
prescriptions for brand name drugs

Avg: 21%

$213
Average prescription price

Avg: $164

NORMAN GORDON M.D.

Neurology

3,752

$921K

339
243 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

28%
prescriptions for brand name drugs

Avg: 21%

$246
Average prescription price

Avg: $164

PETER BELLAFIORE MD

Neurology

3,551

$573K

385
299 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 21%

$161
Average prescription price

Avg: $164

EDWARD DONNELLY MD

Neurology

3,238

$319K

283
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 21%

$99
Average prescription price

Avg: $164

RANDY KOZEL MD

Neurology

3,174

$651K

211
137 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 21%

$205
Average prescription price

Avg: $164

ANDREW BLUM MD, PHD

Neurology

2,472

$530K

133
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 21%

$214
Average prescription price

Avg: $164

VLADISLAV ZAYAS M.D.

Neurology

2,148

$332K

235
119 are 65+

18%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

17%
prescriptions for brand name drugs

Avg: 21%

$154
Average prescription price

Avg: $164

OSCAR BERNAL M.D.

Neurology

2,111

$214K

291
151 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 21%

$101
Average prescription price

Avg: $164

ELAINE JONES MD

Neurology

2,074

$372K

216
172 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 21%

$180
Average prescription price

Avg: $164

MOTASEM AL-YACOUB M.D.

Neurology

2,036

$325K

282
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 21%

$160
Average prescription price

Avg: $164

SYED RIZVI MD

Neurology

1,962

$1.44M

153
31 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

31%
prescriptions for brand name drugs

Avg: 21%

$734
Average prescription price

Avg: $164

FRED GRIFFITH M.D.

Neurology

1,772

$270K

241
174 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 21%

$153
Average prescription price

Avg: $164

GARY JOHNSON MD

Neurology

1,761

$305K

142
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 21%

$173
Average prescription price

Avg: $164

STEPHEN SALLOWAY MD

Neurology

1,747

$234K

176
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

41%
prescriptions for brand name drugs

Avg: 21%

$134
Average prescription price

Avg: $164

CARLO BROGNA M.D.

Neurology

1,669

$177K

155
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

12%
prescriptions for brand name drugs

Avg: 21%

$106
Average prescription price

Avg: $164

ALLA KORENNAYA M.D.

Neurology

1,493

$147K

161
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 21%

$99
Average prescription price

Avg: $164

ANDREW LEKOS M.D.

Neurology

1,170

$114K

53
12 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

33%
prescriptions for brand name drugs

Avg: 21%

$98
Average prescription price

Avg: $164

GRACE MEDEIROS MD

Neurology

1,107

$141K

99
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 21%

$127
Average prescription price

Avg: $164

PETRO KARANASIAS MD

Neurology

1,041

$249K

131
102 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 21%

$239
Average prescription price

Avg: $164

JEFFREY WISHIK MD

Neurology

721

$103K

75
33 are 65+

56%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

30%
prescriptions for brand name drugs

Avg: 21%

$143
Average prescription price

Avg: $164

MICHAEL VECCHIONE D.O.

Neurology

652

$80.8K

90
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

13%
prescriptions for brand name drugs

Avg: 21%

$124
Average prescription price

Avg: $164

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank